1 minute read
Jan. 17, 2022

CC-90001: a JNK Inhibitor for Pulmonary Fibrosis

CC-90001

oral JNK2 kinase inhibitor Ph. II candidate for pulmonary fibrosis from HTS and SBDD Journal of Medicinal Chemistry Celgene (Bristol Myers Squibb), San Diego, CA

drughunter.com
Drug Hunter Team
Reviewer:  

CC-90001 was nominated by reviewer Christian Kuttruff . CC-90001 is a JNK (c-Jun N-Terminal Kinase) inhibitor and a Phase II clinical candidate for idiopathic pulmonary fibrosis ( NCT03142191). Christian says, “Preclinical evidence suggests that c-Jun N-terminal kinase (JNK) enzyme function is required for [...]

Loading...

twitterlinkedinemail

Other molecules you may be interested in